ACTIVE

PHL Médecine

Financial year 2024 · Closed on 31/12/2024

Net result106,3 k €+97,7 %over 1 year
Gross margin135,5 k €+87,8 %over 1 year
Equity163,1 k €+187,3 %over 1 year

Identity

Source · BCE/KBO

PHL Médecine is a Private limited company incorporated in 2023. Its main activity is: Specialist medical practice activities. Its registered office is in Aywaille.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1000.948.245
Incorporation
09/10/2023
Legal form
Private limited company
Registered office
Rue Longchamps 39
4920 Aywaille · WallonieSee on map
Contributed capital
3 000,00 €
Latest accounts
31/12/2024
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 2 filings

Trend over 2 financial years

20242023
Income statement
Gross margin135,5 k €72,2 k €
EBITDA135,1 k €71,8 k €
Operating result135,1 k €71,8 k €
Net result106,3 k €53,8 k €
Balance sheet
Equity163,1 k €56,8 k €
Total assets184,2 k €80,1 k €
Cash96,8 k €36,6 k €
Debts21,1 k €23,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active

Active mandates

Philippe LOUSBERG

Director

Active

Full financial information

Source · NBB
20242023
Type of accountAbridged modelAbridged model
Start of the financial year01/01/202409/10/2023
Closing of the financial year31/12/202431/12/2023
Length of the financial year12 months3 months
Filing date27/08/202514/08/2024
General meeting31/07/202518/07/2024
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 2 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202431/07/202527/08/2025FrenchPDF
Abridged model31/12/202318/07/202414/08/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active

Active mandates

Philippe LOUSBERG

Director

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other11/10/2023
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024106,3 k €↑
  2. 2023
    Annual accounts 202353,8 k €
  3. 09/10/2023
    IncorporationPrivate limited company